InvestorsHub Logo
Post# of 253087
Next 10
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

Re: genisi post# 124872

Tuesday, 08/09/2011 8:14:58 PM

Tuesday, August 09, 2011 8:14:58 PM

Post# of 253087
It's interesting 150mg group was doing numerically better than 300mg group in reduction in both annual relapse rate and risk of sustained disability progression while 300mg group did do better numerically in secondary endpoint than 150mg group.

How many MS drugs BIIB can put on the market?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.